Cognition Therapeutics Falls Below Nasdaq’s $1 Bid-Price Requirement
Nasdaq notified the company on November 3 that its closing bid price had remained below $1.00 for 30 consecutive business days. It has until May 3, 2027, to regain compliance; its shares continue to trade on Nasdaq Capital Market.
On November 3, 2026, Nasdaq notified the company that its closing bid price had remained below $1.00 for 30 consecutive business days, failing Nasdaq Listing Rule 5450(a)(1). The company has until May 3, 2027, to regain compliance; its stock continues to trade on Nasdaq Capital Market with no immed…